Lymphomyeloid Contribution of an Immune-Restricted Progenitor Emerging Prior to Definitive Hematopoietic Stem Cells  by Böiers, Charlotta et al.
Cell Stem Cell
ArticleLymphomyeloid Contribution of an Immune-
Restricted Progenitor Emerging Prior
to Definitive Hematopoietic Stem Cells
Charlotta Bo¨iers,1,2 Joana Carrelha,3 Michael Lutteropp,3 Sidinh Luc,3 Joanna C.A. Green,3 Emanuele Azzoni,4
Petter S. Woll,3 Adam J. Mead,3 Anne Hultquist,1 Gemma Swiers,4 Elisa Gomez Perdiguero,5 Iain C. Macaulay,3
Luca Melchiori,3 Tiago C. Luis,3 Shabnam Kharazi,1 Tiphaine Bouriez-Jones,3 Qiaolin Deng,6 Annica Ponte´n,7
Deborah Atkinson,3 Christina T. Jensen,3 Ewa Sitnicka,1 Frederic Geissmann,5 Isabelle Godin,8 Rickard Sandberg,6
Marella F.T.R. de Bruijn,4 and Sten Eirik W. Jacobsen3,4,9,*
1Haematopoietic Stem Cell Laboratory, Lund Stem Cell Center, Lund University, 221 84 Lund, Sweden
2Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, 221 84 Lund, Sweden
3Haematopoietic StemCell Laboratory, Weatherall Institute ofMolecularMedicine, John Radcliffe Hospital, University of Oxford, Headington,
Oxford OX3 9DS, UK
4MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington,
Oxford OX3 9DS, UK
5Center for Molecular and Cellular Biology of Inflammation, Division of Immunology Infection & Inflammatory Diseases,
King’s College London, London SE1 1UL, UK
6Department of Cell and Molecular Biology, Karolinska Institutet and Ludwig Institute for Cancer Research, 171 77 Stockholm, Sweden
7Cardiovascular group, Lund Stem Cell Center, Lund University, 221 84 Lund, Sweden
8Institut National de la Sante´ et de la Recherche Me´dicale, INSERM 1009, Universite´ Paris-Sud, Orsay, 94805 Villejuif, France
9Department of Cell and Molecular Biology, Wallenberg Institute for Regenerative Medicine and Department of Medicine,
Center for Hematology and Regenerative Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
*Correspondence: sten.jacobsen@imm.ox.ac.uk
http://dx.doi.org/10.1016/j.stem.2013.08.012SUMMARY
In jawed vertebrates, development of an adaptive im-
mune-system is essential for protection of the born
organism against otherwise life-threatening patho-
gens. Myeloid cells of the innate immune system
are formed early in development, whereas lym-
phopoiesis has been suggested to initiate much
later, following emergence of definitive hematopoiet-
ic stem cells (HSCs). Herein, we demonstrate that the
embryonic lymphoid commitment process initiates
earlier than previously appreciated, prior to emer-
gence of definitive HSCs, through establishment
of a previously unrecognized entirely immune-
restricted and lymphoid-primed progenitor. Notably,
this immune-restricted progenitor appears to first
emerge in the yolk sac and contributes physiologi-
cally to the establishment of lymphoid and some
myeloid components of the immune-system, estab-
lishing the lymphomyeloid lineage restriction pro-
cess as an early and physiologically important line-
age-commitment step in mammalian hematopoiesis.
INTRODUCTION
The mammalian hematopoietic system is considered the para-
digmatic and best-understood model for howmultilineage diver-
sity is achieved by stepwise lineage restriction of a multipotentCellstem cell (Orkin and Zon, 2008a). Although multipotent hemato-
poietic stem cells (HSCs) possessing all blood-lineage potentials
have been unequivocally established to reside at the top of the
hematopoietic hierarchy (Osawa et al., 1996), the exact roadmap
for hematopoietic lineage restriction remains disputed, in partic-
ular with regard to the first lineage-restriction steps of HSCs
(Orkin and Zon, 2008a; Schlenner and Rodewald, 2010; Ye and
Graf, 2007). The classical hematopoietic hierarchy still prevailing
in textbooks predicts that the first lineage-restriction decision
made by adult HSCs results in strictly separated pathways for
the lymphoid and myeloerythroid lineages (Orkin and Zon,
2008b; Seita and Weissman, 2010) as supported by the identifi-
cation of common lymphoid (Kondo et al., 1997) and common
myeloid (Akashi et al., 2000; Arinobu et al., 2007) progenitors
(CLPs and CMPs, respectively).
However, earlier in vitro findings demonstrating that clonal
lineage outputs of heterogeneous fetal hematopoietic progeni-
tors excluded combined B and T cell generation in the absence
of myeloid cells, challenged the classical hematopoietic hierar-
chy, and led to the proposal that the first lineage decisions of
HSCs might rather result in a separation into a CMP and a
lymphomyeloid progenitor pathway (Katsura and Kawamoto,
2001), a hypothesis supported by additional studies (Cumano
et al., 1992; Lacaud et al., 1998). More recently, lymphoid-
primed multipotent progenitors (LMPPs) were prospectively iso-
lated and shown at the single-cell level to possess combined
granulocyte-macrophage (GM) and B and T lymphocyte poten-
tial but little or no megakaryocyte-erythroid (MkE) potential
(Adolfsson et al., 2005; Ma˚nsson et al., 2007), providing direct
evidence for the existence of a lymphomyeloid-restricted
pathway in mammalian hematopoiesis. However, the revisedStem Cell 13, 535–548, November 7, 2013 ª2013 Elsevier Inc. 535
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implying that LMPPs possess considerable MkE potential in vivo
(Boyer et al., 2011; Forsberg et al., 2006). Thus, whether the first
lineage fate decision of multipotent stem-progenitor cells results
in establishment of completely separated pathways of the
myeloid and lymphoid components of the immune system or a
common lymphomyeloid immune pathway remains unresolved
(Boyer et al., 2012; Orkin and Zon, 2008a; Schlenner and
Rodewald, 2010; Seita and Weissman, 2010; Ye and Graf,
2007). Moreover, the in vivo physiological relevance of the
lymphomyeloid pathway has been challenged based on in vivo
fate mapping studies concluding that adult lymphomyeloid-
restricted progenitors contribute almost exclusively to lympho-
poiesis and not myelopoiesis (Boyer et al., 2011; Schlenner
et al., 2010; Welner et al., 2009).
Lineage-fate decisions of multipotent stem and progenitor
cells take place for the first time during early embryonic develop-
ment. Blood cells appear in the mouse embryo at embryonic day
(E) 7 in the yolk sac (YS). This first wave of primitive hematopoi-
esis is myeloerythroid-restricted and transient (Medvinsky et al.,
2011). In addition, resident tissue macrophages, such as brain
microglia, liver Kupffer cells, and epidermal Langerhans cells,
develop between E8.5 and E9.5 independently of definitive
HSCs (Schulz et al., 2012). The first definitive multipotent
HSCs, defined as cells capable of long-term repopulation of all
myeloerythroid and lymphoid lineages in adult recipient mice
are not found until after E10.5 (Medvinsky and Dzierzak, 1996).
These HSCs, first generated in the aorta-gonad-mesonephros
(AGM) region, subsequently at E11 seed the fetal liver (FL), the
main fetal hematopoietic site (Kumaravelu et al., 2002; Med-
vinsky and Dzierzak, 1996). Because the first lymphoid-
restricted embryonic progenitors have been identified after
definitive HSCs seed the FL (Douagi et al., 2002), it has been
assumed that lymphoid lineage restriction does not initiate
before the FL is seeded by definitive HSCs. However, there are
several findings compatible with lymphoid lineage commitment
potentially initiating earlier. Progenitors possessing all myeloer-
ythroid and lymphoid lineage potentials have been identified
before emergence of definitive HSCs and FL hematopoiesis
(Kieusseian et al., 2012; Rybtsov et al., 2011; Yoshimoto et al.,
2012) and at E10.5–E11, low-level expression of interleukin-7
receptor alpha (IL7Ra) and the recombination activating gene 1
(Rag1), regulators of early lymphoid development, have been
described in the embryo (Kawamoto et al., 2000; Yokota et al.,
2006) Although the identity of these early IL7Ra and Rag1-ex-
pressing cells has not been investigated in detail, they could
potentially reflect multilineage transcriptional-primed multipo-
tent progenitors (Hu et al., 1997;Ma˚nsson et al., 2007). However,
the earliest IL7Ra-expressing progenitors have rather been sug-
gested to be fully B or T lymphocyte-restricted and to lack
myeloid lineage potential (Kawamoto et al., 2000), coinciding
with or even preceding evidence of lymphomyeloid lineage
restriction, suggesting that B and T lymphoid lineage restriction
might occur independently of a lymphomyeloid lineage restric-
tion step.
Herein we prospectively identified an IL7Ra-expressing lym-
phomyeloid-restricted embryonic progenitor as early as E11.5
that sustains combined lymphoid and GM transcriptional lineage
priming and potential at the single-cell level but lacks MkE536 Cell Stem Cell 13, 535–548, November 7, 2013 ª2013 Elsevier Inpotential. We tracked this lymphomyeloid progenitor back to
E9.5 YS, preceding both hematopoietic colonization of the FL
and the establishment of definitive HSCs. Through in vivo fate
mapping, we confirmed the inability of Rag1-expressing early
embryonic progenitors to significantly contribute to theMkE line-
age while unequivocally and robustly contributing to the myeloid
innate, as well as lymphoid adaptive, immune systems of the
mammalian embryo. These findings identify the developmentally
earliest immune-restricted progenitor and establish the lym-
phomyeloid restriction as a physiologically important lineage-
commitment step in embryonic mammalian hematopoiesis,
preceding the emergence of definitive HSCs.
RESULTS
Interleukin-7 Receptor Expression Defines Immune-
Restricted Embryonic Progenitors with Combined
Lymphoid and Granulocyte-Macrophage Lineage
Potentials
Expression of IL7Ra has been suggested to be restricted to
lymphoid progenitors. We investigated IL7Ra expression in FL
at E11.5 and in agreement with previous findings (Kawamoto
et al., 2000) we found IL7Ra+ cells coexpressing the pan-
hematopoietic marker CD45 and the progenitor cell receptor
c-Kit (Kit) but negative for mature lineage markers (Lin) (Fig-
ure 1A). A large fraction of LinKit+IL7Ra+ cells also expressed
the myeloid colony-stimulating factor 1 receptor (Csf1r) and
the thrombopoietin receptor (ThpoR) (Figure 1A), also expressed
by HSCs (Solar et al., 1998). Most IL7Ra+ cells (>70%) coex-
pressed c-fms-like tyrosine kinase 3 receptor (Flt3) (0.20% of
FL cells; Figure 1B), highly expressed on early lymphomyeloid
progenitors in adult bone marrow (Adolfsson et al., 2005).
Single-cell assays demonstrated that LinKit+Flt3+IL7Ra+
E11.5 FL cells possess considerable GM potential with as
many as 43% of single cells forming GM clones, whereas
virtually no cells (<1%) possessed Mk or E potential (Figures
1C–1F). Single LinKit+Flt3+IL7Ra+ cells generated 31% and
35% of B and T cell progeny, respectively (Figures 1G and 1H).
In vitro cytokine response experiments with the ligands for Flt3
and IL7Ra demonstrated that Flt3 and IL7Ra are expressed at
functionally relevant levels on LinKit+Flt3+IL7Ra+ progenitors
(see Figure S1A available online). However, in contrast to later
emerging B and T lymphoid-restricted progenitors critically
dependent on Flt3 and IL7Ra signaling (Sitnicka et al., 2003),
investigation of embryos genetically deleted for expression of
both Flt3 ligand and the common gamma chain of the IL7R
demonstrated that E11.5 LinKit+Flt3+IL7Ra+ progenitors
emerge independently of Flt3 and IL7R signaling (Figures S1B
and S1C).
Investigation of single LinKit+Flt3+IL7Ra+ E11.5 FL cells
demonstrated that more than 70% coexpressed lymphoid
(Il7r, Rag1, and sIgh) and GM (Csf3r [Gcsfr] and Mpo), but
not the MkE (Vwf, Epor, and Gata1) transcripts typically ex-
pressed by multipotent progenitors with MkE potential (Figures
2A and 2B)(Ma˚nsson et al., 2007). When compared to LinKit+
Flt3IL7Ra cells, the downregulation of MkE-affiliated and
upregulation of lymphoid genes expressed prior to B and
T cell commitment was further verified through single-cell
quantitative gene expression analysis (Figure 2C). Notably,c.
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Figure 1. Interleukin-7-Receptor Expressing Early Fetal Liver Pro-
genitors Have Lymphomyeloid Lineage Potentials
(A) Coexpression of cell-surface IL7Ra, Csf1R (upper panel) and ThpoR (lower
panel) in E11.5 FL LinKit+ progenitors. Viable cells were gated LinCD45+.
Further gating is indicated in the figure. Grey lines represent negative controls.
Mean percentages of LinCD45+Kit+IL7Ra+ cells coexpressing Csf1R or
ThpoR, respectively, are shown (three experiments).
(B) LinKit+Flt3+IL7Ra+ E11.5 FL cell purification by FACS (purity reanalysis
right panel). Mean percentage of total FL cells (>3 experiments) is shown.
(C) GM lineage potential in liquid culture of single LinKit+Flt3IL7Ra and
LinKit+Flt3+IL7Ra+ E11.5 FL cells (white bars represent total cloning; black bars
representclonescoveringR10%ofwell; >350cells per population).Mean±SD.
(D) Bulk-sorted LinKit+Flt3+IL7Ra+ E11.5 FL cells were cultured under
myeloid conditions and evaluated morphologically. Mean ± SD (three biolog-
ical replicates). Right panel shows representative granulocytes.
(E) Erythroid (left panel) and megakaryocyte (right panel) lineage potential of
single LinKit+Flt3IL7Ra and LinKit+Flt3+IL7Ra+ E11.5 FL cells in liquid
culture. Mean percentages ± SD (R450 cells per assay).
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Cellthis single-cell analysis demonstrated that every LinKit+Flt3+
IL7Ra+ progenitor cell expressing these lymphoid genes coex-
pressed myeloid lineage genes, whereas none of them
expressed signature genes of the earliest B (Pax5) and T (Ptcra)
cell restricted progenitors.
Clones derived from single LinKit+Flt3+IL7Ra+ E11.5 FL cells
were analyzed for the combined potential for generation of GM,
B, and T cells (Figures 2D and 2E). Of the single cell-derived
clones that gave a lineage readout, as many as 45% produced
mature cells of all three GM, B, and T cell lineages (GM/B/T; Fig-
ures 2F and 2G). Natural killer (NK) cells, a third lymphoid lineage
and part of the innate immune system, were generated in the
majority of the single cell-derived GM/B/T clones (Figure 2H).
Virtually no erythroid cells were produced even upon
inclusion of erythroid-promoting cytokines (Figure 2I), which
stimulated erythropoiesis from the more heterogeneous
LinKit+Flt3IL7Ra progenitors (Figures S2A and S2B).
Paired immunoglobulin like receptor (PIR) expression has
been shown to separate T and B cell progenitors later in
embryonic development. Specifically, in E13.5, FL T cell
restricted progenitors were found to coexpress IL7Ra and
PIR, whereas B cell progenitors were IL7Ra+PIR (Masuda
et al., 2005). We found that only a small fraction (11%) of
E11.5 FL LinKit+Flt3+IL7Ra+ progenitors expressed cell
surface PIR (Figure 2J). The PIR expression was confirmed
by quantitative PCR and shown to coincide with upregulation
of other early lymphoid transcripts, whereas both PIR+ and
PIR LinKit+Flt3+IL7Ra+ cells expressed myeloid genes (Fig-
ure 2K). In agreement with representing the E11.5 FL
lymphomyeloid-restricted progenitors with combined GM, B,
and T cell potential, LinKit+Flt3+IL7Ra+PIR cells showed
robust readout of all three lineage potentials, whereas the small
fraction of LinKit+Flt3+IL7Ra+PIR+ cells showed reduced T
and undetectable B cell potential (Figure 2L). Thus, at the
time of its first seeding by definitive HSCs, the FL contains
LinKit+Flt3+IL7Ra+ progenitors with combined lympho-
myeloid, but no MkE transcriptional priming or potential.
Emergence of Immune-Restricted Progenitors Prior to
Definitive HSCs
A large number of LinKit+Flt3+IL7Ra+ immune-restricted pro-
genitors (1,200 ± 200 cells/FL) were already present by E11.5.
In contrast, we did not detect any long-term multilineage recon-
stitution activity in E10.5 or E11.5 FL (whether transplanted intra-
venously or directly into the bones), whereas considerable HSC
activity was found in E12.5 FL (Figure 3A; Figures S3A–S3D).
These findings are in agreement with previous studies, which
suggest that there is at most only one definitive HSC in the FL
at E11.5 (Kumaravelu et al., 2002). To enhance the possibility(F) Erythroid (left panel) and megakaryocyte (right panel) potential of
LinKit+Flt3+IL7Ra+ E11.5 FL cells in semisolid medium. Mean percentages ±
SD (600 cells, 3 experiments).
(G) B cell (NK1.1CD19+B220+) and (H) T cell (NK1.1CD25+Thy1.2hi and/or
NK1.1CD4+CD8+) potential of single LinKit+Flt3IL7Ra and LinKit+
Flt3+IL7Ra+ E11.5 FL cells in Op9 and Op9DL1 coculture, respectively.
Representative FACS plots. Mean percentages ± SD (R90 cells per assay),
*p% 0.05.
See also Figure S1.
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Figure 2. Combined GM and Lymphoid
Transcriptional Priming and Lineage Poten-
tials of Single IL7Ra+ E11.5 Fetal Liver
Progenitors
(A) Single-cell RT-PCR analysis of LinKit+Flt3+
IL7Ra+ E11.5 FL cells and (B) combined lineage
transcriptional priming patterns based on (A).
Mean percentages ± SD of total Kit+ cells
(>93%;R130 cells).
(C) Quantitative gene-expression analysis of sin-
gle LinKit+Flt3+IL7Ra+ and LinKit+Flt3IL7Ra
E11.5 progenitors. Expression of early lymphoid
(Flt3, Il7r, Rag2, Ighm), B cell-specific (Pax5),
T cell-specific (Ptcra), myeloid (Csf1r, Csf3r), and
MkE (Epor, Gata1, Klf1) related genes were
determined as D Ct values and normalized to the
mean ofGapdh and Hprt. Each column represents
a single cell (R45 cells per population).
(D) Experimental strategy for establishing com-
bined lineage potentials of LinKit+Flt3+IL7Ra+
E11.5 FL cells. Single cells were deposited directly
into wells with Op9 stroma cells. After 5 days of
culture, cloneswere transferred toOp9DL1 stroma
cells. Clones were analyzed for lineages after
11 days of culture.
(E) Representative FACS profile of LinKit+Flt3+
IL7Ra+ E11.5 FL single-cell-derived GM/B/T
clone. A clone was scored positive for B cells
if containing NK1.1CD19+ cells; T cells if
NK1.1CD19CD25+Thy1.2hi cells and GM cells if
containing NK1.1CD19CD25Thy1.2Mac1+
Gr1-/+ cells.
(F) Cloning frequency (white bar; black bar repre-
sents clones assigned to the GM, B, and/or T
lineage) and (G) lineage (GM/B/T) composition of
lineage-positive clones derived from single
LinKit+Flt3+IL7Ra+ E11.5 FL cells and (H)
frequency of combined GM/B/T clones also con-
taining NK (NK1.1+CD19CD25Thy1.2) cells.
Data in (F)–(H) are mean percentages ± SD (R230
cells investigated).
(I) Frequency of LinKit+Flt3+IL7Ra+ E11.5 FL
progenitors with erythroid potential (clones
with Ter119+CD71+ cells and/or positive by
morphology) on Op9 stroma under conditions
promoting erythroid development. Mean per-
centage ± SD of plated cells (150 cells investi-
gated, 3 experiments).
(J) LinKit+Flt3+IL7Ra+ E11.5 FL progenitors were
fractionated based on expression of PIR. Mean
percentages within LinKit+Flt3+IL7Ra+ compart-
ment (four experiments).
(K) Quantitative gene expression analysis of
lymphoid and myeloid transcripts in LinKit+
Flt3+IL7Ra+PIR and PIR+ cells. Mean ex-
pression ± SD normalized to Hprt (2 biological
replicates, 25 cells per population).
(L) Lineage potentials of single LinKit+Flt3+
IL7Ra+PIR and PIR+ cells. GM potential (left
panel) (white bars represent total cloning; black
bars represent clones covering R10% of well), B
cell potential (middle panel), and T cell potential
(right panel). Mean percentages ± SD; two to three
experiments, *p % 0.05.
See also Figure S2.
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and because expression of Flt3 and Rag1-GFP highly
overlap in LinKit+Flt3+IL7Ra+ E11.5 progenitors (Fig-
ure 3B), we used a Rag1-GFP reporter to identify a distinct
population of LinKit+Rag1GFP+IL7Ra+ E10.5 FL progenitors
(Figure 3C), which possessed GM, B, and T cell, but no
MkE potential, as in the E11.5 FL (Figures 3D–3G; Fig-
ure S3E), establishing that immune-restricted progenitors
are present in the FL already prior to and independently of defin-
itive HSCs.
We next explored how early LinKit+Rag1GFP+IL7Ra+
lymphomyeloid-primed progenitors emerge in the embryo. In
whole E8.5 concepti, virtually noRag1GFP+IL7Ra+-positive cells
were found, neither in the CD45 nor in the small CD45+ fraction
(Figure 3H). Because the first hematopoietic cells to colonize the
FL at E10 might come from the YS, we analyzed YS at E9.5
and observed a small but distinct LinKit+Rag1GFP+IL7Ra+
cell population (30 ± 4 cells/YS; Figure 3I). Notably, whereas
most hematopoietic cells at E9.5 have yet to upregulate expres-
sion of the pan-hematopoietic marker CD45, virtually all LinKit+
Rag1GFP+IL7Ra+ cells were CD45+ although most also ex-
pressed CD41, and a small fraction the endothelial marker
VE-Cadherin (Figure 3J). The placenta and the para-aortic-
splanchnopleura (PAS, to become the AGM) region from E9.5
embryos were also investigated, but no Rag1GFP+IL7Ra+ cells
were detected above background level (Figure 3I).
Almost 80% of the rare purified E9.5 YS LinKit+Rag1GFP+
IL7Ra+ cells expressed combined lymphoid GM but no MkE
transcriptional priming at the single-cell level (Figures 3K and
3L), similar to E11.5 FL LinKit+Flt3+IL7Ra+ cells (Figures 2A–
2B), demonstrating that lymphomyeloid-primed progenitors
emerge as early as E9.5.
To further investigate the embryonic site of origin of the
lymphoid-primed immune-restricted progenitors, whole-mount
imaging of Rag1GFP+ embryos was performed. In agreement
with the fluorescence-activated cell sorting (FACS) analysis,
Rag1GFP+ cells coexpressing CD45 and the endothelial marker
CD31 were localized in the YS at E9.5 in all embryos investigated
(14/14; Figure 3M; Figure S3F), whereas in the PAS region
Rag1GFP+ cells were rarely observed (Figure 3N). Notably, the
majority ofRag1GFP+ cells in the YSwere predominantly located
in close proximity to the primitive vascular plexus, rather than in
large vessels (Figures 3M–3N; Figure S3F). In line with these
data, we also observed transcriptional expression of Rag2 and
Il7r in E9.5 YS but little or no expression in E8.5 embryos or
E9.5 PAS (Figure 3O). These data are most compatible with
LinKit+Rag1GFP+IL7Ra+ cells originating in E9.5 YS. However,
because the connection between the YS and intraembryonic
blood vessels occurs already at E8.5, we next dissected the
YS and PAS regions from Rag1GFP+ embryos before circulation
was established (%6 somite pairs [sp]), short-term cultured the
whole explants, and performed whole-mount immunolabeling
(Cumano et al., 1996). Strikingly, in six out of ten YS explants,
Rag1GFP+ cells coexpressing CD45 and CD31 emerged after
48 hr, as did expression of Il7r and sIgh (Figures 3P and 3Q),
whereas at the same time no Rag1GFP+ cells were generated
by the precirculation PASexplants (seven embryos) (Figure S3G),
supporting that Rag1GFP+IL7Ra+ lymphomyeloid-restricted
progenitors arise de novo in the YS at E9.5.CellRag1+ Immune-Restricted Progenitors Contribute to
Fetal Lymphopoiesis and Myelopoiesis In Vivo
It is important to establish to what degree early lymphoid progen-
itors with sustained myeloid lineage potential in vitro contribute
toward generation of myeloid cells under in vivo physiologically
relevant conditions. Recent studies exploring this in adult hema-
topoiesis have questioned the physiological relevance of the
residual myeloid potential of early lymphomyeloid progenitors
(Boyer et al., 2011; Schlenner et al., 2010; Welner et al., 2009).
Thus, although our in vitro experiments demonstrated that
embryonic immune-restricted progenitors sustain lymphoid
and GM but little or no MkE lineage potentials, they could not
establish the contribution of these Rag1-expressing progenitors
to different hematopoietic cell lineages during embryonic devel-
opment. Thus, we applied a Rag1-Cre fate mapping in which
only cells expressing Rag1 or their progeny will express a yellow
fluorescent protein (YFP). As expected, virtually all B and T cells
emerging later in the fetus were positive for YFP in E14.5 FL (Fig-
ures 4A–4B) as in adult BM (Figure S4A). Moreover, Rag1
expressing progenitors did not contribute to the Mk or E line-
ages, as predicted by our negative in vitro findings and the
lack of MkE transcriptional priming (Figure 4A; Figures S4A
and S4B). However, in contrast to the adult BM, in which we
could confirm that Rag1 expressing progenitors contribute mini-
mally, if at all, to the GM lineage (Figure S4A), 36% of cells of the
GM lineage were YFP+ in E11.5 and 16% in E14.5 FLs (Figures
4A, 4C, and 4D; Figures S4C–S4E). Moreover, while erythroid
colony forming cells were YFP, 20% of granulocyte- and
macrophage-containing colonies were YFP+ in E14.5 FLs (Fig-
ures 4E and 4F). These fate-mapping studies not only confirm
the immune-restricted potentials of LinKit+Rag1GFP+IL7Ra+
progenitors under physiological conditions in the early embryo
but they also demonstrate that early embryonic Rag1-express-
ing progenitors contribute extensively to generation of GM and
lymphoid cells in the embryo. Interestingly, resident tissue mac-
rophages in the form of microglia, liver Kupffer cells, and
epidermal Langerhans cells that develop around E8.5 indepen-
dently of definitive HSCs (Schulz et al., 2012) were only minimally
labeled by YFP (Figure S4F), suggesting that these tissues
macrophages emerge independently of LinKit+Rag1GFP+
IL7Ra+ lymphomyeloid progenitors, in agreement with an origin
prior to the emergence of the herein identified lymphomyeloid-
restricted progenitor.
Upregulation of Lymphoid and Downregulation of MkE
Lineage Programs in Immune-Restricted Progenitors
Prior to Emergence of Definitive HSCs
Genetic experiments have suggested that adult and fetal hema-
topoiesis is largely regulated through distinct molecular path-
ways (Yuan et al., 2012). However, whereas the global gene
expression profiles of adult HSCs and progenitors have been
explored extensively, this has not been feasible with early
embryonic progenitors, partly because they have largely yet to
be prospectively identified but also because of the scarcity of
distinct progenitor cells at these early stages of development.
We applied a recently established protocol for global RNA
sequencing of small cell numbers (Ramsko¨ld et al., 2012) on
purified immune-restricted progenitors in E9.5 YS and E10.5
and E11.5 FLs. We compared expression levels of publishedStem Cell 13, 535–548, November 7, 2013 ª2013 Elsevier Inc. 539
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Embryonic Lymphomyeloid Lineage Restrictionlineage-associated genes (Luc et al., 2012) in immune-restricted
progenitors (LinKit+Rag1GFP+IL7Ra+ or LinKit+Flt3+IL7Ra+)
with the corresponding LinKit+ progenitors lacking expression
ofRag1GFP, Flt3, and IL7Ra. This analysis demonstrated a strik-
ing upregulation of lymphoid and downregulation of MkE tran-
scripts in E11.5 FL immune-restricted progenitors (Figure 5A),
already evident in E10.5 FL and E9.5 YS progenitors
(Figure S5A). In agreement with their virtual lack ofMkE potential,
key MkE regulatory transcripts were markedly downregulated
(Figures 5A and 5B), whereas expression of multiple myeloid
transcripts was sustained (Figures 5A and 5C). Early lymphoid
transcripts were as expected almost undetectable in LinKit+
Rag1GFPIL7Ra and LinKit+Flt3IL7Ra progenitors, but
markedly upregulated in immune-restricted progenitors at
E9.5–E11.5 (Figures 5A and 5D; Figures S5A and S5B). In agree-
ment with our single-cell PCR analysis, early B cell (Cd79a, Ebf1,
Pax5, Vpreb1) and T cell (Cd3e, Cd8a, Ptcra) restricted tran-
scripts were not expressed in E9.5 YS or E11.5 FL in neither
the immune-restricted nor the control progenitors (Figures S5C
and S5D), in support of B and T cell-restricted progenitors
emerging later in fetal development, or at least not as part of
the herein identified LinKit+Rag1GFP+IL7Ra+ or LinKit+Flt3+
IL7Ra+ immune-restricted progenitors.
Because the thymic anlage is seeded at E11.5 (Owen and
Ritter, 1969), we also investigated the expression of genes impli-
cated in regulation of thymus seeding progenitors (TSPs).
Whereas LinKit+Rag1GFPIL7Ra and LinKit+Flt3IL7Ra
cells expressed little or no Ccr7 and Ccr9, encoding two chemo-
kine receptors critically involved in the migration of embryonicFigure 3. Emergence of Lymphomyeloid Progenitors Coexpressing Ra
(A) Unfractionated E10.5 (1 FL/recipient), E11.5, and E12.5 (3–4 FLs per recipie
recipients. Left panel, total donor; right panel, myeloid reconstitution (dotted lin
Numbers indicate frequencies of mice reconstituted.
(B) LinKit+Rag1GFP+IL7Ra+ cells in E11.5 FL were analyzed for expression of Fl
panel). Mean percentages expression, gray line represents control (representativ
(C) Coexpression of IL7Ra and Rag1-GFP in LinKit+ progenitors in E10.5 (30–3
(D) Myeloid (single cells; left panel), megakaryocyte (single cells; middle panel), an
cells. Mean ± SD (>150 cells per assay, 3–5 experiments).
(E) Representative morphology of macrophages (left panel) and granulocytes (
indicated by arrows.
(F) B cell (NK1.1CD19+) and (G) T cell (NK1.1CD25+Thy1.2hi and/or NK1.1CD
E10.5 FL cells. Mean percentages ± SD.
(H) Lack of expression of IL7Ra and Rag1-GFP in the E8.5 (4–7 sp) conceptus.
panels show expression analysis on CD45 and CD45+ cells, respectively (2 exp
(I) Coexpression of IL7Ra and Rag1-GFP in different tissues at E9.5 (14–26 sp); P
gated negative for lineage markers; further gating is indicated with arrows. Mean
(J) Expression of CD45, CD41, and VE-Cadherin within the E9.5 YS LinKit+Rag
(K) Single-cell RT-PCR analysis in LinKit+Rag1GFP+IL7Ra+ E9.5 YS progenitors
percentages ± SD of total Kit+ cells (>91%;R50 cells, 2 experiments).
(M) Confocal image of a whole-mount immunolabeled E9.5 (23sp)Rag1GFP YS. A
One of these (boxed area) is enlarged to show fluorescence in the individual cha
(N) Left panel shows the number of GFP+ cells per E9.5 YS and embryo proper
distribution of GFP+ cells within individual YS analyzed, as cells localized in the v
(O) Whole embryos at E8.5 and PAS and YS from E9.5 embryos were analyze
(normalized to Hprt; 2–4 biological replicates). *, not detected.
(P) Explant culture of precirculation Rag1-GFP YS (%6 sp), were immunolabeled
YS explant (1 sp). The boxed area is enlarged and individual channels are show
Scale bar represents 50 mm.
(Q) Precirculation PAS and YS were analyzed after 48 hr explant culture for Il7r an
Hprt; 3 biological replicates).
See also Figure S3.
CellTSPs to the thymus (Liu et al., 2006), both were markedly
upregulated in E11.5 FL immune-restricted progenitors and in
the case of Ccr7 already at E9.5 (Figure 5E). Likewise, key regu-
latory genes in early T cell development such as Gata3, Hes1,
Notch1, and Tcf7 (Rothenberg, 2007) were markedly upregu-
lated in E9.5 and E11.5 immune-restricted progenitors (Fig-
ure 5E), compatible with these progenitors possessing TSP
potential.
When E9.5–E11.5 immune-restricted progenitors were
compared to adult CLPs and LMPPs, investigated lymphoid
genes were typically expressed at higher levels than in adult
LMPPs (not further separated based on Rag1-GFP expression),
but in most cases lower than adult CLPs (Figures 5D and 5E; Fig-
ure S5B). Selected MkE, GM, lymphoid, and TSP-related tran-
scripts found to be differentially expressed in embryonic
immune-restricted cells were further validated with quantitative
PCR, confirming the same pattern of gene expression (Figures
S6A–S6D). When analyzing the most significantly upregulated
transcripts in E9.5 YS LinKit+Rag1GFP+IL7Ra+ (compared to
LinKit+Rag1GFPIL7Ra) cells and in LinKit+Flt3+IL7Ra+
E11.5 FL (compared to LinKit+Flt3IL7Ra) cells, 67 transcripts
were found to be commonly upregulated at both E9.5 and E11.5
(Figure 6; Tables S1–S3). Notably, the majority of these genes
were almost exclusively overrepresented in Gene Ontology
Categories related to development or function of the immune
system (Figure 6), further supporting the emergence of lympho-
myeloid-primed progenitors as an early embryonic commitment
step toward establishing a fully competent mammalian immune
system.g1-GFP and IL7Ra in E9.5 Embryos
nt) FL cells were competitively transplanted into lethally irradiated wild-type
e represents detection level [background staining]; 0.1% donor contribution).
t3 (upper panel) and LinKit+Flt3+IL7Ra+ cells for Rag1-GFP expression (lower
e of 12 embryos investigated).
8 sp) FL cells. Mean percentage of total cells (5 experiments).
d erythroid (BFU-E; right panel) potential of LinKit+Rag1GFP+IL7Ra+ E10.5 FL
right panel) derived from sorted LinKit+Rag1GFP+IL7Ra+ E10.5 FL cells as
4+CD8+) potential (4 cells per well, 3 experiments) of LinKit+Rag1GFP+IL7Ra+
Viable cells were gated negative for mature lineage markers. Middle and right
eriments).
AS (left panel), placenta (middle panel), and YS (right panel). Viable cells were
percentages of total cells (3 experiments).
1GFP+IL7Ra+ population. Mean percentages of parent gate (3 experiments).
and (L) combined transcriptional lineage priming patterns based on (K). Mean
rrows indicate GFP+ cells in the vascular plexus coexpressing CD31 and CD45.
nnels. Original magnification 2503. Scale bar represents 100 mm.
respectively (mean ± SD, 11–14 embryos). ***p % 0.001. Right panel shows
ascular plexus or in less branched larger vessels.
d for Rag2 and Il7r expression by quantitative PCR. Mean expression ± SD
to detect the presence of Rag1GFP+ cells. Representative confocal image of a
n for a GFP+ cell coexpressing CD31 and CD45. Original magnification 2503.
d sIgh expression by quantitative PCR. Mean expression ± SD (normalized to
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Figure 4. Rag1 Expressing Immune-
Restricted Progenitors Contribute to Em-
bryonic Myelopoiesis
(A)Rag1-Cre fatemapping inE11.5FLandE14.5FL
from Rag1-Cretg/+R26ReYFP/+ embryos. Histo-
grams show percentage of YFP+ cells of total
Mac1+ (Ter119CD150CD41) myeloid cells,
CD19+ B cells, CD41+CD150+ (Ter119CD19
Mac1Gr1) megakaryocytes, and Ter119+
(CD19Mac1Gr1CD41CD150) erythroid cells.
Mean percentages of parent gate (8 or 9 embryos).
(B) Rag1-Cre fate mapping in E14.5 thymus.
Histogram shows percentage of YFP+ cells of
Kit+CD25+ (LinCD4CD8) DN1 thymocytes.
Mean percentages of parent gate (4 embryos).
(C) Percentages YFP+ cells of total Mac1+ myeloid
cells in E11.5 FL, E14.5 FL, and adult BM. Each
dot represents one individual mouse or embryo.
(D) Morphological distribution of cell types within
Mac1+Gr1+YFP+ (CD19B220Ter119CD150
CD41) and Mac1+Gr1YFP+ (CD19B220
Ter119CD150CD41) cells sorted from Rag1-
Cretg/+R26ReYFP/+ E14.5 FLs. Mean percentages
(2 experiments).
(E) Mean percentages ± SD of YFP+ GM (left) and
erythroid (right) colonies generated from un-
fractionated E14.5 Rag1-Cretg/+R26ReYFP/+ FL
cells (GM; 12 individual embryos, >1000 colonies,
Erythroid; 9 individual embryos, 218 colonies).
(F) Morphological distribution of cell types within
YFP and YFP+ myeloid colonies generated from
E14.5 Rag1-Cretg/+R26ReYFP/+ FL cells in semi-
solid culture. Mean percentage ± SD (5 embryos).
Right panel shows representative granulocytes
from YFP+ colony.
See also Figure S4.
Cell Stem Cell
Embryonic Lymphomyeloid Lineage RestrictionDISCUSSION
Although other recent studies have carefully documented the
emergence of progenitors with substantial lymphoid potential
already in the E9.5 YS, as evaluated in cultures and upon trans-
plantation (Yoshimoto et al., 2012), it has remained unclear
whether or not this lymphoid potential comes from a multipotent
progenitor in the YS or an already partially or fully lymphoid-
restricted progenitor. Ncx1 knockout embryos fail to develop a
beating heart and therefore lack a circulation. Investigation of
Ncx1 null embryos provided compelling evidence for the emer-
gence in the YS of progenitors with considerable lymphoid
potential as established through their ability in long-term cultures
and upon transplantation to produce fetal, as well as adult type,
T cells (Yoshimotoet al., 2012).However, theprogenitors respon-
sible for this activity were not prospectively identified, and it was
not established whether the cells producing only T cells in the
long-term assays might also possess other lineage potentials.
In fact, in another study it was shown that the same E9.5 YS cells
also have B cell potential when assessed in other assays (Yoshi-
moto et al., 2011). The present studies suggest that the T and B542 Cell Stem Cell 13, 535–548, November 7, 2013 ª2013 Elsevier Inc.lymphoid potential observed in the E9.5
YS by Yoshimoto et al. might derive at
least in part frommultipotent but lympho-
myeloid-restricted progenitors.Through prospective purification, molecular characterization,
and fate mapping, the findings herein establish that extensive
lymphoid transcriptional priming and lymphomyeloid-lineage
restriction initiates in the YS at E9.5, earlier than previously
recognized, before the emergence of definitive HSCs and estab-
lishment of FL hematopoiesis. This restriction occurs through the
establishment of distinct immune-restricted progenitors with
combined lymphoid and myeloid lineage potentials (Figure 7),
defined by upregulation of specific regulators of lymphopoiesis:
Rag1, Flt3, and IL7Ra, as well as a number of other lymphoid-
specific transcripts. Importantly, single-cell lineage-potential
assays, as well as in vivo fate mapping of their progeny during
normal embryonic development, confirmed not only the virtual
absence of MkE potentials but also the physiological and robust
contribution to themyeloid (GM), as well as lymphoid, lineages in
the developing embryo.
The lymphomyeloid-primed progenitors already detected in
E9.5 YS and E10.5 FL represent the earliest identified embryonic
progenitors in which specific and key lymphoid gene expression
is initiated, coexpressed with myeloid genes, and paralleled by a
distinct downregulation of MkE genes, similar to the LMPPs
Cell Stem Cell
Embryonic Lymphomyeloid Lineage Restrictionidentified later in development (Adolfsson et al., 2005; Ma˚nsson
et al., 2007). The lymphoid genes expressed in these embryonic
progenitors were early common lymphoid genes, whereas early
B and T cell progenitor-specific genes were found to be
negative, in agreement with previous studies supporting that B
and T cell lineage commitment occurs later in FL hematopoiesis
(Douagi et al., 2002), or at least not within the herein identified
lymphomyeloid-restricted progenitors. Moreover, every
LinKit+Flt3+IL7Ra+ progenitor cell expressing these lymphoid
genes coexpressed at the single-cell level myeloid lineage genes
even in the E11.5 FL, whereas none of them expressed signature
genes of the earliest B (Pax5) and T (Ptcra) cell-restricted progen-
itors. In light of these findings, we suggest that earlier studies
implicating the emergence of fully B or T lymphoid-restricted
progenitors already in the E10–10.5 AGM region and fetal
circulation, based on evaluation of clonal lineage output of heter-
ogenous progenitor populations (Ikawa et al., 2004; Ohmura
et al., 1999), might have missed the myeloid output of lympho-
myeloid-restricted progenitors as a result of the short lifespan
of myeloid cells in culture. Regardless, establishment of whether
also fully lymphoid-restricted progenitors might emerge prior
to definitive HSCs would require their prospective purification
and molecular evidence of fully lymphoid-restricted progenitor
cells.
The most significantly upregulated genes in embryonic lym-
phomyeloid-restricted progenitors were almost exclusively
related to development or function of the immune system,
including genes demonstrated to be of critical importance for
establishment of thymopoiesis (Rothenberg, 2007), implicating
early embryonic lymphomyeloid progenitors as candidate
TSPs. Findings of Yoshimoto et al. (2012) showing that there
are cells with thymus reconstitution potential already in the
E9.5 YS and PAS region, combined with our identification in
E9.5 YS of distinct lymphomyeloid-primed progenitors with up-
regulated expression of genes for chemokine receptors, critically
involved in migration of TSPs to the embryonic thymus, raises
the possibility that TSPs responsible for initiation of thymopoie-
sis in the embryo might be generated in the YS.
Our analysis of different hematopoietic regions in the embryo
by FACS, whole-mount imaging, and PCR analysis suggest that
the identified lymphomyeloid-restricted progenitors emerge first
in the YS at E9.5, a finding further supported by precirculation
explant short-term cultures of the YS and PAS regions. The iden-
tity of the hematopoietic stem-progenitor cells giving rise to this
first wave of lymphomyeloid-restricted progenitors remains to be
established. Although their early emergence rules out an origin
from definitive HSCs, they might derive from hemogenic endo-
thelium in E9.5 YS as suggested in recent studies (Yoshimoto
et al., 2012) and as further supported by our finding ofRag1GFP+
cells in the primitive vascular plexus in the E9.5 YS. Alternatively,
they might derive from multipotent progenitors in the YS, also
possessing MkE potential, or potentially from recently identified
candidate pre-HSCs (Figure 7B).
Previous studies have proposed the existence of mouse
lymphomyeloid-restricted progenitors in FL hematopoiesis
(Cumano et al., 1992; Katsura and Kawamoto, 2001; Lacaud
et al., 1998), and the LMPP was later prospectively identified in
adult hematopoiesis as well as in E14.5 FL (Adolfsson et al.,
2005; Arinobu et al., 2007; Ma˚nsson et al., 2007). AlthoughCellcollectively these studies provided compelling experimental
support for a revised hematopoietic hierarchy with separate
CMP and lymphomyeloid immune-restricted pathways (re-
viewed in (Luc et al., 2008b), this has not precluded the concep-
tually classical CMP-CLP roadmap from still prevailing in the
literature (Orkin and Zon, 2008a, b; Seita and Weissman,
2010). This controversy reflects in part that all studies supporting
either model have relied exclusively on the ability of nonphysio-
logical in vitro and in vivo reconstitution assays to uncover
lineage potentials of the prospectively purified progenitor cells.
Thus, although these studies have been instrumental for our
current understanding of lineage commitment, the assays
applied do have intrinsic caveats (Richie Ehrlich et al., 2011).
Perhaps even more relevant, uncovering of multiple lineage
potentials of a progenitor cell in vitro or upon in vivo transplanta-
tion into conditioned recipients does not address whether and to
what degree the progenitor in question contributes (or not) under
normal in vivo physiological conditions toward the different cell
lineage potentials.
Although genetic fate-mapping experiments in vivo could
address these fundamentally important questions, it remains
a considerable challenge to develop strategies that would
faithfully allow lineage tracing of distinct progenitor cells.
Results from recent Flt3 lineage-tracing studies questioned
the physiological relevance of an early lymphomyeloid line-
age-restriction step in hematopoiesis (Boyer et al., 2011,
2012), although the conclusions were limited by Flt3 expres-
sion initiating already in fully multipotent progenitors (Boyer
et al., 2012; Buza-Vidas et al., 2011). Another recent Il7r fate-
mapping study also questioned the myeloid contribution and
the physiological significance of a lymphomyeloid-restricted
pathway (Schlenner et al., 2010; Schlenner and Rodewald,
2010), as did Rag1 fate mapping in adult hematopoiesis
(Welner et al., 2009). However, only a small fraction of adult
lymphomyeloid-restricted LMPPs express Il7r or Rag1 (Adolfs-
son et al., 2005; Luc et al., 2008a), and Rag1+ LMPPs have
considerably reduced myeloid potential as compared to
Rag1 LMPPs (Luc et al., 2008a). In contrast, we here demon-
strate that early embryonic lymphomyeloid-restricted progeni-
tors express much higher levels of Il7r and Rag1, and when
applying Rag1-Cre fate mapping, we could for the first time
demonstrate that lymphomyeloid-restricted progenitors con-
tribute extensively to myelopoiesis, as well as lymphopoiesis
during normal fetal development. Of equal importance, we
found no significant contribution of Rag1-expressing progeni-
tors to the MkE lineages in vivo, confirming their immune-
restricted role. Thus, our combined lineage potential and
fate-mapping studies establish the existence of lymphomye-
loid-restricted progenitors in early embryonic hematopoiesis
prior to emergence of definitive HSCs, and their physiological
contribution to both the myeloid innate and lymphoid adaptive
immune system. Notably, the existence of lymphomyeloid-
restricted progenitors has also recently been implicated in
early postnatal and adult human hematopoiesis (Doulatov
et al., 2010; Goardon et al., 2011; Kohn et al., 2012).
The identification of an embryonic immune-restricted progen-
itor is of relevance for childhood acute lymphoblastic leukemia
(cALL), the most common form of pediatric cancer. Preleukemic
translocations in cALL frequently occur in utero in unidentifiedStem Cell 13, 535–548, November 7, 2013 ª2013 Elsevier Inc. 543
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GO annotation FDR Coverage
B cell activation 2.42E-02 6 / 147
immunoglobulin production 2.42E-02 5 / 69
T cell differentiation 2.42E-02 6 / 154
external side of plasma membrane 2.42E-02 7 / 229
production of molecular mediator of immune response 3.34E-02 5 / 97
T cell activation 3.93E-02 7 / 274
B cell proliferation 6.68E-02 4 / 60
lymphocyte differentiation 6.68E-02 6 / 203
regulation of lymphocyte differentiation 2.68E-01 4 / 88
leukocyte differentiation 3.80E-01 6 / 296
E9.5 E11.5
13422
Statistically over-represented Gene Ontology Categories
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Prss2
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Psmb9
Ptprc
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Rgs1
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Serpinb1a
Sesn1
Snn
Sp100
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Tnip3
Tnni2
Tsc22d1
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Zcchc18
Commonly upregulated genes in E9.5 and E11.5 
immune-restricted progenitors
Gem
Gimap6
Gimap7
Gngt2
Gpr171
Gpr65
Gsn
Hmgn3
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Ifitm3
Figure 6. Upregulation of Immune-Related Genes in E9.5 Yolk Sac
and E11.5 Fetal Liver Immune-Restricted Progenitors
Venn diagram showing overlap of upregulated genes in E9.5 YS LinKit+
Rag1GFP+IL7Ra+ (compared to LinKit+Rag1GFPIL7Ra) cells and E11.5 FL
LinKit+Flt3+IL7Ra+ (compared to LinKit+Flt3IL7Ra) cells. Of these 67
overlapping genes, 64 were also upregulated in E10.5 FL LinKit+
Rag1GFP+IL7Ra+ cells (data not shown). Also shown are Gene Ontology
Categories in which common upregulated genes were significantly enriched.
Note that almost all of these categories are related to the immune system.
See also Figures S5 and S6 and Tables S1–S3.
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Embryonic Lymphomyeloid Lineage Restrictionprogenitors (Greaves andWiemels, 2003), also resulting in poor-
prognosis biphenotypic leukemias with characteristics of the
lymphoid and the GM, but not MkE lineages (Be´ne´, 2009). Our
identification of immune-restricted progenitors emerging in the
embryo prior to definitive HSCs and establishment of FL
hematopoiesis will also facilitate a better understanding of the
molecular determinants and cellular pathways required for the
development of a fully competent innate and adaptive immune
system and of how this process is dysregulated in the conglom-
erate of congenital immune deficiencies (Cunningham-Rundles
and Ponda, 2005).Figure 5. Upregulation of Lymphoid and Downregulation of MkE
Progenitors
(A) E11.5 LinKit+Flt3+IL7Ra+ and LinKit+Flt3IL7Ra E11.5 FL cells were subjec
of previously published lineage-associated (MkE, Myeloid [GM], and Lymphoid) pr
of exon model per million mapped reads) values are shown on a log10 scale. *, RP
both cell populations, specific values are indicated next to bars.N, infinity.
(B–E) Expression as determined by RNA sequencing of (B) MkE, (C) GM, (D) lymph
progenitors. Adult HSCs and adult LMPPs are shown as controls. Graph legend fo
RPKM ± SD (2–3 experiments).
*, not detected; #, expressed but at too low level to be visualized on the applied s
experiment.
See also Figures S5 and S6.
CellEXPERIMENTAL PROCEDURES
Animals and Cell Preparations
Embryos were obtained by timed mating, with the morning of vaginal plug
detection set as E0.5. Animal experiments were performed according to reg-
ulations by the local animal ethics committee at Lund University and the UK
Home Office at University of Oxford. For details, see Supplemental Experi-
mental Procedures.
Fluorescence Activated Cell Sorting
Dissected tissues and adult BM (>8 weeks old) were treated with purified anti-
CD16/32 (Fc-block) and stained with antibodies specified in Supplemental
Experimental Procedures. Adult HSCs and progenitors were defined with
the following markers: adult HSCs; LSKCD150+CD48, LMPPs; LSKFlt3hi,
CLPs; LinCD11cLy6CCD19B220Ly6DKitloScaloFlt3+IL7Ra+; proB
cells; Kit+CD19+B220+CD43+.
In Vitro Cultures
Evaluation of MkE and GM lineage potentials was performed as previously
described with minor modifications (Supplemental Experimental Procedures)
(Adolfsson et al., 2005; Luc et al., 2008a; Ma˚nsson et al., 2007). Erythroid line-
age potential was additionally evaluated on Op9 coculture with cytokines
as specified in Supplemental Experimental Procedures. Clones were consid-
ered positive for erythroid development if cells had a Ter119+CD71+
(Mac1Gr1CD150CD41) FACS profile and/or by positive morphology on
May-Gru¨nwald/Giemsa stained cytospins. For evaluation of lymphoid poten-
tial or combined potential, cells were plated onto Op9 or Op9DL1 stroma cells
with cytokines as previously described (Ma˚nsson et al., 2007) (see Supple-
mental Experimental Procedures).
Rag1-Cre Fate Mapping
Rag1-Cretg/+R26ReYFP/+ and littermate Rag1-Cre+/+R26ReYFP/+ control adult
BM and FLs (E11.5 and E14.5) were stained as specified in Supplemental
Experimental Procedures. Adult Flt3-Cretg/+R26ReYFP/+ BM was used as a
positive control to demonstrate that the R26 promoter sustains YFP expres-
sion in all mature (B, T, Mk, and E) lineages as previously shown (Buza-Vidas
et al., 2011) (for further details, see Supplemental Experimental Procedures).
Explant Cultures and Imaging
The YS and PAS regions were dissected from staged embryos (%6 sp) prior to
establishment of circulation as previously described (Cumano et al., 1996),
cultured individually, and then whole-mount immunolabeled, or explants
were taken for quantitative PCR (see Supplemental Experimental Procedures).
In Vivo Reconstitution Experiments
FL cells from E10.5 (32–44 sp), E11.5, and E12.5 CD45.2 embryos were trans-
planted together with 250,000–300,000 competitor CD45.1 BM cells into
lethally irradiated (23 450cGy) C57/Bl6 WT CD45.1 mice, either intravenously
or intrafemorally as specified (in some cases CD45.1 embryos were used and
transplanted into CD45.2 WT recipients). Peripheral blood (PB) analyses were
conducted at 15–17 weeks (see Supplemental Experimental Procedures).
Mice were considered reconstituted if R0.1% donor contribution to total
CD45+ cells was achieved.Transcriptional Programs in Early Embryonic Immune-Restricted
ted to global RNA sequencing and analyzed for differences in expression levels
ograms (Luc et al., 2012). Mean fold differences in RPKM ( = reads per kilobase
KM%0.05 for both cell populations. For genes with expression%0.5 RPKM for
oid, and (E) thymus-seeding progenitor related genes, in E9.5 YS and E11.5 FL
r (B)–(E) is shown in the box to the right. Numbers indicate fold difference. Mean
cale; andN, infinity as not detected in one of the two cell populations in either
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Figure 7. Lymphoid-Myeloid Lineage Re-
striction in the Mouse Embryo Occurs Inde-
pendently of and Precedes Emergence of
Definitive HSCs
(A) Lymphomyeloid lineage restriction after emer-
gence of definitive HSCs. Model for initiation of
lymphomyeloid lineage restriction based on pub-
lished data suggesting that the first lymphoid re-
striction steps occurs after emergence of definitive
HSCs in the aorta-gonad-mesonephros (AGM)
region and their subsequent seeding of the fetal
liver. According to this model, the first lympho-
myeloid progenitors (for which the exact lineage
potentials at the single-cell level remains unclear)
emerge at about E12 followed by generation of
B and T lymphoid restricted progenitors at E13.5
or later.
(B) Initiation of lymphomyeloid lineage restriction
preceding emergence of definitive HSCs.
Initiation of lymphomyeloid lineage restriction
based on the identification of a Rag1GFP+IL7Ra+
immune-restricted progenitor at E9.5 in yolk sac
and E10.5 in fetal liver, prior to emergence of
definitive HSCs in the AGM region. This early im-
mune-restricted progenitor contributes to myelo-
poiesis (GM) already at E11.5 and later to B
and T cell restricted progenitors but little or not
to megakaryo-erythropoiesis. The immune-
restricted progenitor emerges in the yolk sac prior
to definitive HSCs, which is compatible with orig-
inating from proposed hemogenic endothelium,
pre-HSCs, or earlier multipotent progenitors, as
indicated.
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Embryonic Lymphomyeloid Lineage RestrictionSingle-Cell and Quantitative PCR
Multiplex single-cell RT-PCR and multiplex quantitative real-time PCR analysis
(BioMark 48.48 or 96.96 Dynamic Array platform [Fluidigm] with TaqMan Gene
Expression Assays [Applied Biosystems]) were performed as described in Sup-
plementalExperimentalProcedures (Adolfssonetal., 2005;Ma˚nssonetal., 2007).
RNA Sequencing
Samples for RNA sequencing (73–100 cells) were prepared with the SMARTer
Ultra Low RNA kit for Illumina Sequencing (Clontech) and sequenced and
analyzed as previously described (Ramsko¨ld et al., 2012) (see Supplemental
Experimental Procedures).
Statistics
Statistical significance was determined by one or two-tailed (depending on hy-
pothesis) unpaired Mann Whitney (nonparametric) test. The significance level
was set at p% 0.05. Unless otherwise stated, data are shown as mean ± SD.
ACCESSION NUMBERS
The RNA sequencing data have been deposited in NCBI GEO under accession
number GSE50896.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, three tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
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